Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioCryst Pharmaceuticals - 31 Year Stock Price History | BCRX

Historical daily share price chart and data for BioCryst Pharmaceuticals since 1994 adjusted for splits and dividends. The latest closing stock price for BioCryst Pharmaceuticals as of May 21, 2025 is 10.07.
  • The all-time high BioCryst Pharmaceuticals stock closing price was 33.12 on August 25, 2000.
  • The BioCryst Pharmaceuticals 52-week high stock price is 11.11, which is 10.3% above the current share price.
  • The BioCryst Pharmaceuticals 52-week low stock price is 5.92, which is 41.2% below the current share price.
  • The average BioCryst Pharmaceuticals stock price for the last 52 weeks is 7.72.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
BioCryst Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 8.2399 7.8300 11.0300 6.4100 10.0700 33.91%
2024 6.5994 6.0700 8.6900 4.1300 7.5200 25.54%
2023 7.6484 11.4500 11.8400 4.9800 5.9900 -47.82%
2022 12.9217 14.0700 19.7600 7.8900 11.4800 -17.11%
2021 13.2588 7.3750 17.6500 7.3700 13.8500 85.91%
2020 4.0566 3.4000 8.6100 1.6000 7.4500 115.94%
2019 5.0056 8.5000 9.7200 1.5850 3.4500 -57.25%
2018 6.2900 5.4400 9.6000 4.3500 8.0700 64.36%
2017 5.7481 6.3600 9.2000 4.1000 4.9100 -22.43%
2016 4.1766 9.8000 9.8000 1.6600 6.3300 -38.66%
2015 11.2628 12.1400 16.3900 8.1000 10.3200 -15.13%
2014 10.9308 7.9000 13.9600 7.3700 12.1600 60.00%
2013 3.6788 1.6300 7.6400 1.1900 7.6000 435.21%
2012 3.6217 2.3900 5.6100 1.2600 1.4200 -42.51%
2011 3.4155 5.3400 5.3400 2.2900 2.4700 -52.22%
2010 6.1336 6.8000 8.2900 4.5500 5.1700 -19.97%
2009 5.6855 1.5000 12.8000 1.1600 6.4600 371.53%
2008 3.0655 6.0300 6.4100 0.8800 1.3700 -77.83%
2007 8.7276 11.1700 12.7700 5.8900 6.1800 -46.54%
2006 13.9796 17.2070 22.4100 8.4900 11.5600 -30.99%
2005 7.9136 5.8100 17.6500 3.7900 16.7500 189.79%
2004 6.7775 6.6200 11.1500 4.5200 5.7800 -15.62%
2003 4.1089 0.9600 9.1400 0.8200 6.8500 613.54%
2002 2.5580 4.2000 5.9000 0.7500 0.9600 -75.76%
2001 4.9603 8.0313 8.0313 3.2000 3.9600 -40.23%
2000 22.7360 28.0000 33.1250 5.4375 6.6250 -77.54%
1999 15.2859 7.1250 32.0000 6.3750 29.5000 321.43%
1998 7.2251 7.1250 9.0000 4.5625 7.0000 0.00%
1997 11.4834 15.7500 17.0000 6.1250 7.0000 -57.25%
1996 12.6782 9.2500 19.0000 9.0000 16.3750 77.03%
1995 8.1406 4.8750 12.8750 4.7500 9.2500 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.162B $0.451B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.830B 32.20
Zoetis (ZTS) United States $72.858B 27.18
Daiichi Sankyo, - (DSNKY) Japan $48.987B 24.92
Takeda Pharmaceutical (TAK) Japan $45.406B 9.03
Sandoz Group AG (SDZNY) Switzerland $21.173B 0.00
Summit Therapeutics (SMMT) United States $18.114B 0.00
Merck (MKKGY) Germany $17.092B 12.52
United Therapeutics (UTHR) United States $13.964B 12.35
Shionogi (SGIOY) Japan $13.347B 13.37
Neurocrine Biosciences (NBIX) United States $12.169B 41.68
IPSEN (IPSEY) France $9.836B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $8.083B 65.71
Stevanato Group S.p.A (STVN) Italy $7.365B 45.04
Madrigal Pharmaceuticals (MDGL) United States $6.500B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.528B 0.00
Ionis Pharmaceuticals (IONS) United States $5.486B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.777B 14.53
Soleno Therapeutics (SLNO) United States $3.782B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.010B 10.55
Crinetics Pharmaceuticals (CRNX) United States $2.937B 0.00
Hypermarcas (HYPMY) Brazil $2.857B 18.79
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.326B 12.58
NewAmsterdam Pharma (NAMS) Netherlands $2.125B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.850B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.764B 0.00
Guardian Pharmacy Services (GRDN) United States $1.677B 0.00
Indivior (INDV) United States $1.577B 6.69
Evotec AG (EVO) Germany $1.445B 0.00
ARS Pharmaceuticals (SPRY) United States $1.407B 0.00
Dyne Therapeutics (DYN) United States $1.403B 0.00
Ocular Therapeutix (OCUL) United States $1.211B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.121B 22.43
Harrow (HROW) United States $1.030B 0.00
Ardelyx (ARDX) United States $1.000B 0.00
Collegium Pharmaceutical (COLL) United States $0.963B 5.19
Avadel Pharmaceuticals (AVDL) Ireland $0.906B 0.00
Enliven Therapeutics (ELVN) United States $0.853B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.767B 0.00
AleAnna (ANNA) United States $0.669B 0.00
KalVista Pharmaceuticals (KALV) United States $0.609B 0.00
Xencor (XNCR) United States $0.579B 0.00
Bioventus (BVS) United States $0.574B 14.56
USANA Health Sciences (USNA) United States $0.559B 12.16
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.545B 0.00
Savara (SVRA) United States $0.542B 0.00
Relay Therapeutics (RLAY) United States $0.523B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
CytoDyn (CYDY) United States $0.485B 0.00
Altimmune (ALT) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.473B 0.00
Zevra Therapeutics (ZVRA) United States $0.471B 0.00
Siga Technologies (SIGA) United States $0.443B 9.25
Tourmaline Bio (TRML) United States $0.416B 0.00
Organogenesis (ORGO) United States $0.414B 0.00
Verve Therapeutics (VERV) United States $0.411B 0.00
Oruka Therapeutics (ORKA) United States $0.398B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.360B 9.72
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.85
Aquestive Therapeutics (AQST) United States $0.237B 0.00
ProKidney (PROK) United States $0.232B 0.00
MediWound (MDWD) Israel $0.226B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.219B 0.00
Wellgistics Health (WGRX) United States $0.191B 0.00
OmniAb (OABI) United States $0.188B 0.00
Nanobiotix S.A (NBTX) France $0.181B 0.00
Esperion Therapeutics (ESPR) United States $0.180B 0.00
4D Molecular Therapeutics (FDMT) United States $0.178B 0.00
Avita Medical (RCEL) United States $0.177B 0.00
Liminatus Pharma (LIMN) $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Korro Bio (KRRO) United States $0.152B 0.00
Profound Medical (PROF) Canada $0.151B 0.00
Inhibikase Therapeutics (IKT) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.146B 0.00
Aldeyra Therapeutics (ALDX) United States $0.141B 0.00
Protara Therapeutics (TARA) United States $0.134B 0.00
Larimar Therapeutics (LRMR) United States $0.132B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.130B 0.00
Nektar Therapeutics (NKTR) United States $0.128B 0.00
Lyell Immunopharma (LYEL) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lexeo Therapeutics (LXEO) United States $0.117B 0.00
VAXART, INC (VXRT) United States $0.116B 0.00
Achieve Life Sciences (ACHV) Canada $0.113B 0.00
Cassava Sciences (SAVA) United States $0.108B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.106B 0.00
Fractyl Health (GUTS) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.093B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Champions Oncology (CSBR) United States $0.086B 14.09
Galectin Therapeutics (GALT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Inotiv (NOTV) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 55.89
Pyxis Oncology (PYXS) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.073B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Unicycive Therapeutics (UNCY) United States $0.072B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.055B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.051B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.048B 0.00
Karyopharm Therapeutics (KPTI) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
DURECT (DRRX) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.68
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00